JP2016539190A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539190A5
JP2016539190A5 JP2016554939A JP2016554939A JP2016539190A5 JP 2016539190 A5 JP2016539190 A5 JP 2016539190A5 JP 2016554939 A JP2016554939 A JP 2016554939A JP 2016554939 A JP2016554939 A JP 2016554939A JP 2016539190 A5 JP2016539190 A5 JP 2016539190A5
Authority
JP
Japan
Prior art keywords
polypeptide
formula
group
heteroarylene
alkenylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016554939A
Other languages
English (en)
Japanese (ja)
Other versions
JP6609563B2 (ja
JP2016539190A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/066300 external-priority patent/WO2015079376A1/en
Publication of JP2016539190A publication Critical patent/JP2016539190A/ja
Publication of JP2016539190A5 publication Critical patent/JP2016539190A5/ja
Application granted granted Critical
Publication of JP6609563B2 publication Critical patent/JP6609563B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016554939A 2013-11-26 2014-11-24 ケトンで修飾されたポリペプチドをオキシム複合化する方法 Expired - Fee Related JP6609563B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361909236P 2013-11-26 2013-11-26
US61/909,236 2013-11-26
US201462002614P 2014-05-23 2014-05-23
US62/002,614 2014-05-23
PCT/IB2014/066300 WO2015079376A1 (en) 2013-11-26 2014-11-24 Methods for oxime conjugation to ketone-modified polypeptides

Publications (3)

Publication Number Publication Date
JP2016539190A JP2016539190A (ja) 2016-12-15
JP2016539190A5 true JP2016539190A5 (cg-RX-API-DMAC10.html) 2018-01-18
JP6609563B2 JP6609563B2 (ja) 2019-11-20

Family

ID=52117931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016554939A Expired - Fee Related JP6609563B2 (ja) 2013-11-26 2014-11-24 ケトンで修飾されたポリペプチドをオキシム複合化する方法

Country Status (15)

Country Link
US (1) US10172948B2 (cg-RX-API-DMAC10.html)
EP (1) EP3074048B1 (cg-RX-API-DMAC10.html)
JP (1) JP6609563B2 (cg-RX-API-DMAC10.html)
KR (1) KR20160088429A (cg-RX-API-DMAC10.html)
CN (1) CN105764530B (cg-RX-API-DMAC10.html)
AU (1) AU2014356126B2 (cg-RX-API-DMAC10.html)
CA (1) CA2928087A1 (cg-RX-API-DMAC10.html)
EA (1) EA201691075A1 (cg-RX-API-DMAC10.html)
ES (1) ES2729643T3 (cg-RX-API-DMAC10.html)
IL (1) IL245244A0 (cg-RX-API-DMAC10.html)
MX (1) MX2016006674A (cg-RX-API-DMAC10.html)
TW (1) TWI572361B (cg-RX-API-DMAC10.html)
UY (1) UY35854A (cg-RX-API-DMAC10.html)
WO (1) WO2015079376A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201602603B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013350802B2 (en) 2012-11-30 2016-07-14 Novartis Ag Methods for making conjugates from disulfide-containing proteins
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
SG11201701565PA (en) 2014-09-03 2017-03-30 Immunogen Inc Conjugates comprising cell-binding agents and cytotoxic agents
US20190194315A1 (en) 2015-06-17 2019-06-27 Novartis Ag Antibody drug conjugates
WO2017051254A1 (en) * 2015-09-25 2017-03-30 Legochem Biosciences, Inc. Compositions and methods related to anti-egfr antibody drug conjugates
WO2017055582A1 (en) 2015-10-01 2017-04-06 Novo Nordisk A/S Protein conjugates
CR20180229A (es) 2015-10-29 2018-08-24 Novartis Ag Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll
HUE067016T2 (hu) 2015-11-25 2024-09-28 Ligachem Biosciences Inc Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások
CN107847605B (zh) 2015-11-25 2021-12-24 乐高化学生物科学股份有限公司 包含分支接头的抗体-药物缀合物及其相关方法
KR102468989B1 (ko) * 2016-11-18 2022-11-22 가고시마 유니버시티 IgG 결합 펩타이드를 포함하는 고상 담체 및 IgG의 분리 방법
JP7664680B2 (ja) 2017-03-29 2025-04-18 リガケム バイオサイエンシズ, インク. ピロロベンゾジアゼピン二量体前駆体及びそのリガンド-リンカーコンジュゲート化合物
AR111651A1 (es) 2017-04-28 2019-08-07 Novartis Ag Conjugados de anticuerpos que comprenden agonistas del receptor de tipo toll y terapias de combinación
US11827703B2 (en) 2018-05-09 2023-11-28 Legochem Biosciences, Inc. Compositions and methods related to anti-CD19 antibody drug conjugates
US12391939B2 (en) 2018-07-23 2025-08-19 The Governors Of The University Of Alberta Genetically-encoded bicyclic peptide libraries
KR20210096115A (ko) * 2018-11-28 2021-08-04 더 거버너스 오브 더 유니버시티 오브 알버타 약물작용 발생단이 내재된 유전자-암호화된 거대고리형 펩타이드 라이브러리
KR20210028544A (ko) 2019-09-04 2021-03-12 주식회사 레고켐 바이오사이언스 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239110B1 (en) 1990-02-22 2001-05-29 W.R. Grace & Co. -Conn. Synthetic analogs of thrombospondin and therapeutic use thereof
WO1999013062A1 (en) 1997-09-09 1999-03-18 Nycomed Imaging As Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
WO1999013063A1 (en) 1997-09-09 1999-03-18 Nycomed Imaging As Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
GB0316294D0 (en) * 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
US8673848B2 (en) 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
WO2008157380A2 (en) 2007-06-15 2008-12-24 Adherex Technologies Inc. Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses therefor
US20110172126A1 (en) 2008-09-03 2011-07-14 Xenome Ltd Libraries of peptide conjugates and methods for making them
DK2889624T3 (en) 2009-08-10 2018-12-10 Ucl Business Plc Reversible covalent bonding of functional molecules
SG11201502757QA (en) 2012-10-09 2015-05-28 Igenica Biotherapeutics Inc Anti-c16orf54 antibodies and methods of use thereof
WO2014078623A2 (en) 2012-11-15 2014-05-22 Brandeis University Tethering cysteine residues using cyclic disulfides
AU2013350802B2 (en) * 2012-11-30 2016-07-14 Novartis Ag Methods for making conjugates from disulfide-containing proteins

Similar Documents

Publication Publication Date Title
JP2018509394A5 (cg-RX-API-DMAC10.html)
CN111225918B (zh) 具有三环部分的Toll样受体7(TLR7)激动剂、其缀合物及其方法和用途
US20250302985A1 (en) Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereof
US11505525B2 (en) Branched discrete PEG constructs
JP2025108689A (ja) カンプトテシンコンジュゲート
RU2015119561A (ru) Новые конъюгаты лекарственное вещество-белок
JP2015526434A5 (cg-RX-API-DMAC10.html)
JP6609563B2 (ja) ケトンで修飾されたポリペプチドをオキシム複合化する方法
JP2017503011A5 (cg-RX-API-DMAC10.html)
EP3668869A1 (en) 6-amino-7,9-dihydro-8h-purin-8-one derivatives as toll-like receptor 7 (tlr7) agonists as immunostimulants
JP2016512425A5 (cg-RX-API-DMAC10.html)
TW201920181A (zh) 具有經雜原子連接之芳香族部分之類鐸受體7(tlr7)促效劑,其結合物及其等之方法及用途
RU2015146614A (ru) Конъюгированная вакцина на основе пептида антигена wt1
JP2012518029A5 (cg-RX-API-DMAC10.html)
JP2017504606A5 (cg-RX-API-DMAC10.html)
JP2018510864A5 (cg-RX-API-DMAC10.html)
JP2023010733A (ja) γ-アマニチンの誘導体
JP2016153410A5 (cg-RX-API-DMAC10.html)
WO2015118031A2 (en) Antibody-drug conjugates and immunotoxins
JP2020506685A5 (cg-RX-API-DMAC10.html)
JP2014516991A5 (cg-RX-API-DMAC10.html)
CA2653941A1 (en) Substituted amino purine derivatives and uses thereof
WO2015118030A2 (en) Antibody-drug conjugates and immunotoxins
JP2016536342A5 (cg-RX-API-DMAC10.html)
JP2017533886A5 (cg-RX-API-DMAC10.html)